AA
JAZZ icon

AQR Arbitrage’s Jazz Pharmaceuticals JAZZ Stock Holding History

AQR Arbitrage’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,224
Closed -$6.5M – 588
2025
Q4 		$6.5M Buy
38,224
+4,902
+15% +$752K 0.14% 192
2025
Q3 		$4.34M Sell
33,322
-47,698
-59% -$5.72M 0.11% 200
2025
Q2 		$8.6M Sell
81,020
-9,118
-10% -$990K 0.2% 141
2025
Q1 		$11M Buy
90,138
+48,320
+116% +$6.3M 0.26% 122
2024
Q4 		$5.15M Buy
+41,818
New +$4.93M 0.11% 175
2021
Q1 		– Sell
-4,919
Closed -$803K – 1185
2020
Q4 		$803K Buy
+4,919
New +$733K 0.03% 509
2020
Q1 		– Sell
-7,659
Closed -$1.14M – 580
2019
Q4 		$1.14M Buy
7,659
+982
+15% +$134K 0.02% 295
2019
Q3 		$849K Sell
6,677
-2,404
-26% -$322K 0.01% 287
2019
Q2 		$1.27M Sell
9,081
-7,391
-45% -$993K 0.01% 272
2019
Q1 		$2.35M Buy
16,472
+753
+5% +$98.2K 0.03% 224
2018
Q4 		$1.95M Buy
15,719
+3,470
+28% +$515K 0.03% 230
2018
Q3 		$2.06M Buy
+12,249
New +$2.11M 0.02% 238

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AQR Arbitrage's JAZZ Position: Q1 2026 in Review

AQR Arbitrage sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 38,224 shares — an estimated $6.5M sold.

AQR Arbitrage first reported a position in JAZZ in Q3 2018 and held it in 12 quarters. The position peaked at $11M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • AQR Arbitrage reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AQR Arbitrage sold 38,224 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.5M.
  • AQR Arbitrage first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 12 quarters.
  • AQR Arbitrage's Jazz Pharmaceuticals position peaked at $11M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.